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Abstract in English
Development of human B-lymphocytes is a convoluted process. A self-renewing stem cell
progenitor in a primary lymphoid tissue commits to the lymphoid lineage. Subsequent
B-lineage commitment entails somatic gene recombination processes which lead to the
eventual expression of a surface antigen receptor. Functionality of the B-cell receptor, as
well as successful testing for autoreactivity by the cell, are preconditions for the differenti-
ation of a mature B-lymphocyte. Processes within this development are often investigated
using single-cell analysis via flow cytometry, fluorescence-activated cell sorting and mass
cytometry. Coupling these high-throughput methods with modern approaches to data
analysis carries enormous potential in revealing rare cell populations and aberrant events
in haematopoiesis.
Keywords: B-lymphocyte, lymphopoiesis, flow cytometry, FACS, mass cytometry, clus-
ter analysis, FlowSOM, PCA, t-SNE, Wanderlust.
Abstrakt v češtině
Vývoj lidských B-lymfocytů je spletitým dějem. Samoobnovující se kmenový progeni-
tor v primární lymfoidní tkáni je nejdříve předurčen k vývoji v lymfoidní linii. Vývoj
B-buněčnou cestou pak zahrnuje somatické genové rekombinace, které vedou k expresi
povrchového antigenního receptoru. Funkčnost B-buněčného receptoru a podrobení buňky
testování na autoreaktivitu jsou podmínkami pro diferenciaci ve zralý B-lymfocyt. Děje v
rámci tohoto vývoje jsou často zkoumány pomocí single-cell analýzy skrze průtokovou cy-
tometrii, fluorescencí aktivované třídění buněk a hmotnostní cytometrii. Propojení těchto
vysoce výkonných metod s moderními přístupy k analýze dat skýtá obrovský potenciál v
nacházení vzácných buněčných populací a odchylných událostí v rámci krvetvorby.
Klíčová slova: B-lymfocyt, lymfopoéza, průtoková cytometrie, FACS, hmotnostní cy-
tometrie, shluková analýza, FlowSOM, PCA, t-SNE, Wanderlust.
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The topics of this thesis are human lymphopoiesis and its examination using single-cell
approaches. I focus on fate decisions and checkpoints during the development of B-
lymphocytes from progenitor cells. Flow and mass cytometry are discussed as highly
useful tools for gathering data which help immunologists understand the dynamics of how
cells within the B-lineage evolve. Some modern approaches to the analysis of cytometric
data are discussed and evaluated as an essential part of the overall narrative.
Flow cytometry is an exciting technique which allows for measurement of size, gran-
ularity and fluorescence from tags which are added to a cell. Both surface and intracellular
markers can be used to identify different cell populations. Moreover, fluorescence-activated
cell sorting can be used to physically sort cells according to the data measured.
Mass cytometry is a newer technique which addresses the issue of spectral overlap
and disentangling emission spectra (compensation) when measuring fluorescence. Using
metal-tagged antibodies, the panel of markers can be expanded radically.
However, processing datapoints which exist in many dimensions is not straight-
foward. A number of fascinating algorithms for the automated visualisation and clustering
of cell populations exists; some are presented in this work.
The development of B-lymphocytes (B-cells) in humans is among the processes
which cytometry has helped to elucidate. Starting in fetal liver or adult bone marrow, stem
cells differentiate into specialised cells, interacting with their surroundings, transcribing
different genes. After commitment to the B-cell lineage, machineries for somatic gene
recombination are assembled and immunoreceptors are gradually built. An immature and
naïve B-cell with a functional receptor, after testing for autoreactivity, can then migrate
to secondary lymphoid organs and play a role in humoral and cell-mediated immunity.
I created this work because I believe in the usefulness of gathering large amounts of
data and using automatised computational analysis to uncover developmental trajectories
of cells. It seems essential for life sciences to explore algorithmisation and machine learning
to reveal these trajectories. For biologists to disregard this type of work would mean
conceding one of the most exciting parts of scientific inquiry to others.
1.1 Aims
This work aims to evaluate the use of flow and mass cytometry for understanding hu-
man haematopoiesis, in particular human B-cell lymphopoiesis, and to describe B-cell
lymphopoiesis. Moreover, it strives to present some principles of data analysis, as they
pertain to processing cytometric data relevant to research into haematopoiesis.
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2 Single-cell analysis
Analysis of single cells provides opportunities for examining differential expression of var-
ious genes and presence of markers. With increasing numbers of parameters which can be
measured with single-cell technologies such as flow cytometry, fluorecence-activated cell
sorting and mass cytometry, interpreting high-dimensional data is of great interest. These
methods need to be addressed prior to discussing B-lymphopoiesis, as I will refer to them
throughout.
2.1 Flow cytometry and cell sorting
Let us evaluate the principles which underly cytometry. A full historical overview is not in
order, yet it is reasonable to review some older techniques also. Flow cytometry originated
from a cell separator described by Fulwyler (1965). The apparatus would vibrate a cell
suspension in a conducting medium to isolate single cells in droplets, so as to enable
measurement of distinct events. The droplets would emerge in quick succession from
a fluid jet. An electrostatic field between two deflection plates would then sort them
according to volume.
The charging pulse needed for correct deflection would be determined beforehand,
using the principle of a Coulter counter: before exiting through the jet, each cell in the
medium would pass through a narrow orifice, causing a drop in current proportional to
the volume of conducting fluid blocked from passing through. This drop would, in turn,
be proportional to the volume of the cell (patented by Hogg and Coulter, 1971).
Flow cytometry added the ability to measure light scatter (which is pertinent to
size and granularity) and fluorescence properties of single cells (or other particles) in
the analyte (described in Van Dilla et al., 1969; reviewed by Adan et al., 2017). Two
components are at play: the fluidics (inspired by Fulwyler) and the optics, coupled with
detectors to acquire data of interest. If the machine retains the ability to sort cells, this
is most commonly done based on fluorescence detection, termed fluorescence-activated
cell sorting (FACS; Herzenberg et al., 1976). As opposed to the Fulwyler separator, the
deflection parameter is a function of fluorescence, not volume.
2.1.1 Fluidics
A suspension of particles is injected into a stream of sheath fluid (most often phosphate-
buffered saline). The coaxial flow of the analyte and sheath fluid (i.e. the flow along
a common axis) aligns the particles in a single file. The stream of cells remains at the
center of the flow cell. This focusing occurs due to the sample stream being injected at a
greater pressure than that of the other concentric streams; the sample does not mix with
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the surrounding sheath fluid (reviewed by Wilkerson, 2012).
2.1.2 Optics
The optical system includes a light source (often a laser) and other components for redi-
rection and collection of light. The light is focused by a lens before reaching the analyte,
and a set of optical filters and mirrors is used to deliver light of different wavelengths to
photomultipliers and detectors.
Fluorescence and two light scatter properties are measured. The forward scatter
parameter (FSC) measures the amount of light which travels forward, further along the
path toward and past the analyte, allowing for only small change in angle. The side scatter
parameter (SSC) measures the amount of light reflected upon reaching the cell. The former
is a correlate of cell size, the latter of granularity in the cell structure (summmarised in
Ormerod, 2008). A schematic representation of a flow cytometer can be seen below (figure
1).
Figure 1. Schematic representation of a generic flow cytometer, adapted from Adan et
al. (2017).
2.1.3 Fluorescent probes
The light source in a cytometer provides energy for electron excitation in the atoms of
a fluorochrome. Subsequently, the electrons return to their ground state, losing energy
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and emmitting a quantum of light. Thus, the optics of a flow cytometer measure both
the autofluorescence and emission of light by fluorescent dyes added to detect surface or
internal markers characteristic of particular cell types (Adan et al., 2017).
In an early paper which describes flow cytometry (as cell microfluorometry ; Van
Dilla et al., 1969), Feulgen staining, based on hydrolysis of DNA, was used to analyse the
cell cycle of Chinese hamster ovaries by viewing a histogram of fluorescence intensity at
different wavelengths. Here, peaks in signal were found to correlate with the G1 (diploid)
and G2 (tetraploid) phases of the cycle.
Later, nucleic-acid intercalators like ethidium-bromide (also used in gel electrophore-
sis) were used to monitor DNA content to understand kinetics of adenoviral infection
(Lemay and Collyn-d’Hooghe, 1984). DNA replication caused by the infection could be
detected as an increase in signal and was compared with a mock infection by a DNA-
negative control virus.
Morevover, the intercalating 4’,6-diamidino-2-phenylindole (DAPI), binding to mi-
nor grooves in DNA, is often used. First employed to isolate mitochondrial DNA (Williamson
and Fennell, 1974), DAPI is currently used in some panels as a marker for dead cells, as
it cannot permeate the membrane of a live cell. For instance, Sonn et al. (2016) in-
clude DAPI for identifying circulating tumor cells, demonstrating usefulness of DAPI in
an oncological study.
Simmons et al. (1991) used various mouse anti-human antibodies (primary Ab)
and goat anti-mouse immunoglobulin G (IgG; secondary Ab) conjugated with fluorescein
isothiocyanate (FITC; one of the commonly used dyes) which would bind to CD34–a
marker of lymphocyte precursors in the bone marrow (see section 3). This is an example
of primary and secondary antibody use in immunochemical staining.
Dead cells can be detected by incorporating another fluorescent intercalator, pro-
pidium iodide (PI), into DNA. This was used by Kikushige, et al. (2008). In addition,
a range of markers to detect progenitors in the myeloid and lymphoid lineage of cells
(important in the immune system; see section 3) was added. For instance, an anti-hFlt-3
antibody was used to mark a receptor tyrosine kinase associated with myeloid progenitors,
which go on to become erythrocytes, granulocytes, megakaryocytes or monocytes, partly
due to the signalling enabled by this receptor. The antibody was stained with FITC,
emitting green light. This is an example where the fluorochrome is bound directly to the
primary antibody, with no need for a secondary antibody.
Some laboratories use immunoglobulins conjugated with the water-soluble biotin
(vitamin B7). At basic pH, biotin substitutes an amino-group of one the amino-acids which
make up the Ig. The biotinylated antibody acquires high affinity for avidin, a tetrameric
protein which forms stable covalent bonds with biotin. This system is often employed in
immunohistochemistry (Bratthauer, 2010).
8
Biotinylation was used by Garvy and Riley (1994), who focused on the role of the
cytokine interleukin-7 (IL-7) in B-cell development. In order to stain for IL-7 receptors (see
section 3.2), the team used biotinylated IL-7 conjugated with avidin-linked phycoerythrin
(PE). Furthermore, in a nine-parameter immunophenotyping study by Bigos et al. (1999),
the authors boosted efficiency of their CD1 staining (marking MHC class I molecules) by
using a biotin-streptavidin link. Streptavidin, boasting a lower propensity for unwanted
non-specific binding, was conjugated with a Texas Red dye. The use of biotin and avidin
or streptavidin showcases the opportunities to strengthen the staining of cell markers.
2.2 Mass cytometry
Mass cytometry was first described by Bandura et al. (2009) as a novel technique for
multitarget immunoassays. Based on mass spectrometry, it would reap the benefits of
using plasma for high throughput and prove itself useful for various analyses.
In contrast with classical flow cytometry, mass cytometry uses elemental metal tags
to detect distinct cellular markers, providing a narrower bandwidth of emission. This is
to reduce spectral overlaps and do away with the need for data compensation (see section
2.3.1).
As reported in cytometric studies where many parameters of interest are examined
simultaneously, the issue of spectral overlaps is the principal factor limiting maximum
numbers of parameters and interpretability of data (Roederer, 2001).
To understand mass cytometry, we need to review the technologies which precede
it. One of the approaches to secure a stable and fast throughput of cells is to vaporise
the analyte and inject it into a stream of plasma. (Plasma is a state of matter where the
behaviour of gaseous ions is mainly governed by long-range electric and magnetic fields.)
For inductively coupled plasma (ICP), the energy for the gradual phase transition from gas
to plasma is supplied by electromagnetic induction. Nomizu et al. (2002) applied these
principles to detect airborne zinc particles by recording a signal via electron multipliers.
Prior to this, the group (1994) demonstrated that individual cells can also be injected into
this stream to detect endogenous calcium.
Becker et al. (2007) describe the use of a nebuliser to create aerosol from biological
tissue and using argon as a carrier gas. The analyte was delivered to an ICP source
and single ions were detected and sorted by varying mass-to-charge (m/z ) ratios. The
m/z variable, an important value in mass spectrometry, is the focus of interest for the
researcher, who seeks to identify abundances of ions of particular mass-to-charge ratio in
a given sample.
One of the approaches to obtaining a mass spectrum in a spectrometer is to acceler-
ate the ionised particles and deflect them in a magnetic field. With changes in energy that
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is supplied to an electromagnet, the severity of deflection is modified and disparate sets of
ions are delivered to a detector (described in Glish and Vachet, 2003). With time-of-flight
(TOF, time until detection of particle) and the m/z parameter correlated, we can em-
ploy these principles in a generic CyTOF (Cytometry-by-Time-of-Flight) mass cytometer,
measuring time until detection of different metal tags.
2.3 Data processing
Processing data gathered by the aforementioned techniques is an interesting topic to ex-
plore. Computer analysis allows the researcher to manipulate data manually, as well as
to employ automation. The latter option is of growing importance.
In order to increase reproducibility of experimental results, the common FCS (Flow
Cytometry Standard) file format for storing cytometric data was proposed in 1984 by
Murphy and Chused. The FCS format records fluorescence and light scatter values, as
well as time parameters and other information for the purpose of annotation and preserving
changes made to the raw data by processing. The FCS 3.0 standard allowed for larger
datasets and extended support for cluster analyses (Seamer et al., 1997).
2.3.1 Compensation
Researchers are often confronted with overlapping emmission spectra in their experimental
panel of fluorochromes. This causes a signal from one fluorochrome to appear in multiple
channels. Compensation seeks to disentangle these spectra. Parks et al. (1977) were
the first to achieve this, with a protocol to compensate overlaps from fluorescein and
rhodamine signals. In the experiment, expression of two different antigens on IgM and
IgD molecules (different isotypes of antibody) from murine spleen was investigated. Prior
to this experiment, the two markers on the mouse lymphocyte sample would have had to
undergo separate analyses. (An example of this, rather elaborate, approach was presented
by Curbelo et al. /1976/. In their design, cells would flow through a capillary and up to 8
distinct optical measurements would be acquired. /A system resemblant of microfluidics–
another prominent single-cell technology./)
The Parks paper presents a novel approach which permitted the team to measure
their two signals at a single interrogation point for each cell and to unravel the data during
measurement. A fluorochrome-specific and filter-specific constant needed to be determined
empirically to quantify the size of interference between the channels. Measurements were
corrected by added electronics which would divert some signal to the other detector, taking
into account the differences in amplification between channels.
Nonetheless, the system proved inefficient, as the circuitry needed to perform real-
time compensation grew quickly in size with each new parameter and the setting yielded
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poor results with more than 4 parameters. Bagwell and Adams (1993) tackled the issue
of scalability with a software approach, where a matrix showing crossovers between any
two parameters is calculated.
Roederer et al. (2001) conducted compensations on a CD8-Cy5-Phycoerythrin con-
jugate (staining mainly Tc cells, emmitting far-red light) and CD4-Phycoerythrin (staining
mainly Th cells, emmitting yellow light). The team showed further advantages of software-
based data manipulation. Ceasing to measure fluorescence on a logarithmic scale (which
is used for visualisation of fluorescence parameters), they would measure data on a linear
scale and transform it later. This proved to minimise errors.
2.3.2 Gating
Gating, the principal step in cytometry data analysis, is the act of separating a population
of cells based on light scatter properties or differential expression of markers. An example
of a gating strategy applied to a dataset can be seen below (figure 2).
Figure 2. A partial gating strategy adapted from Lechner et al. (2015), illustrated using
dot-plots. FSC-A and SSC-A refers to forward-scatter and side-scatter area, i.e. the
integral of signal intensity as a function of time. Light scatter parameters are displayed
on a linear scale, others are log-scaled.
2.3.3 Dimensionality reduction via PCA and t-SNE
Analysing cytometric data using 2-dimensional dot-plots is constraining. For instance, to
reveal the relationships between each pair of parameters in a 12-parameter panel, 66 two-
dimensional dot-plots must be constructed (i.e. the sum of all positive integers smaller
than 12). By this logic, a 30-parameter mass cytometric panel would warrant 435 dot-
plots.
To tackle the issue of multiple dimensions, some techniques allow projections of
data such that dimensionality is reduced to 2 or 3 dimensions. Principal component
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analysis (PCA) considers a matrix X of fluorescence intensities per event. Very generally,
this is reinterpreted as a product of (1) some matrix of baseline values and (2) another
matrix explaining variation versus the baseline. The second matrix is built by identifying
which non-correlated linear combinations of the original variables (rows/columns of X )
contribute to the variance within this dataset the most. Only these newly calculated
parameters (called principle components) are then used in visualising the data (Wold
et al., 1987).
Geometrically, principle components can be imagined as multiple lines of best fit
through the dataset. If we imagine our dataset as a 3-dimensional ‘cloud’ of points, the
first PC intersects the cloud along its longest axis, the second PC is perpendicular and
the third PC is orthogonal. The two or three axes of a resulting graph will correspond
to these components and all the data will be mapped into this space. The same principle
of constructing PCs as lines through a cloud of data can be applied to datasets of higher
dimensionality. Some residual variation, not explained by the approximation provided by
PCA, will be present in the original matrix – in an ideal situation, this will only be noise
in the data.
Lugli et al. (2007) designed an 8-colour panel to investigate differences in the T-
lymphocyte compartment between donor age groups. The team gated data based on light
scatter properties (lymphocyte gate), CD3 expression (marking T-lymphocytes) and CD4
versus CD8 (Th vs Tc cells). Thereafter, other markers, including CD127 (an interleukin-7
receptor subunit, involved in survival), CD95 (the first apoptosis signal receptor, involved
in cell death) or CD38 (a glycoprotein involved in cell adhesion and activation), were used
to create ‘positive’ and ‘negative’ gates (or, with CD38, ‘negative’, ‘bright’ and ‘dim’).
Groups of cells based on (1) donor group and (2) combination of positivities/negativities
were then subjected to PCA, yielding three principal components (PCs). The study
elaborates on the use of various data normalisation methods used prior to the analysis.
Figure 3 shows one of the PCA-generated graphs from the study.
Figure 3. An example of a 3-d plot based on PCA on CD4+ T-cells (adapted from Lugli
et al., 2007). Distribution of cell populations on a principal component (PC) scales are
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displayed, with metrics of influence attributed to each component. Each PC is a linear
function of the measured fluorescence parameters.
After observing that groups of cells were mapped to different positions based on
donor age, the team would report on the most striking differences (for instance, with regard
to CD4+ cells, a CD127+CD95-CD38dim phenotype was identified as largely characterising
young donors and a CD127-CD95+ phenotype seemed typical for cenentarians – people
over 99 years of age).
A more prevalent technique for dimensionality reduction, currently of great im-
portance to cytometrists, is t-distributed stochastic neighbour embedding (t-SNE). Van
der Maaten and Hinton (2008) address the issue of assuming linearity, warning that tech-
niques including PCA ‘focus on keeping the low-dimensional representation of dissimilar
datapoints far apart ’, yet it is often ‘more important to keep the low-dimensional repre-
sentations of very similar datapoints close together.’ Moreover, they introduced t-SNE:
an algorithm for visualising data while preserving much of the local structure and some
of the global structure of high-dimensional data.
The original stochastic neighbour embedding algorithm, introduced by Hinton and
Roweis (2002), uses a probabilistic approach to determining neighbourhood of events. This
means that for each point i in the dataset, a ‘probability’ is computed that it picks any
other one point j as its neighbour. This is achieved by imagining a straight line connecting
the two points. Then, a Gaussian (bell-shaped) curve is drawn along the line, so that the
center of the curve (the peak) is at i. Dissimilarity between the points increases with
decrease in the height of the curve at j (i.e. value of the Gaussian function at j ). The
width of the Gaussian curve is manipulated with each new i according to local entropy:
generally, the denser the region is, the narrower the curve is, and vice versa. To map all
the datapoints in a space with fewer dimensions, they are mapped stochastically, then
rearranged. Based on dissimilarities in the original space, dissimilar points repel, whereas
similar points attract.
The t-SNE algorithm (Hinton and Roweis, 2002) makes some changes to the original
SNE algorithm, including the use of t-distribution instead of Gaussian distribution. Figure
4 shows a typical t-SNE graph. The problem of ‘overcrowding’ is inherent for t-SNE, with
the reduction of dimensions resulting in space constraints. A novel method of hierarchical
stochastic neighbour embedding (HSNE) offers the capability to run multiple SNE analyses
in iterations, identifying representative ‘landmark’ cells and passing them as input to
another SNE level. This reduces the need for downsampling, and the analysis boasts good
performance in identifying rare immune cell types, as tested on samples from patients with
gastrointestinal disorders (Van Unen et al., 2017).
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Figure 4. An sample output of viSNE (software implementation of t-SNE), as applied to
a mass cytometric analysis of healthy human bone marrow, with stains for 13 markers.
Some populations gated manually by an expert (in bright colours) were clearly separated
into distinct regions by the t-SNE algorithm itself. Adapted from Amir et al. (2013).
2.3.4 Cluster analysis using self-organising maps
Many different algorithms are available for automatised identification of clusters of events
within a dataset (some are reviewed by Weber and Robinson, 2016). These can be used
as tools for identifying cell populations. For the sake of brevity, a single implementation,
that of self-organising maps (SOMs), is discussed here.
Van Gassen et al. (2015) set out to implement a fast technique for both visu-
alisation and interpretation of data from cytometry. Interestingly enough, they cite a
study (Kohonen, 1998) which describes an architecture for mapping large amounts of tex-
tual documents in English as points on a grid. Kohonen communicates a ‘self-teaching’
algorithm which creates a self-organising map, accounting for similarities between repre-
sentative samples of text from each document. Each sample is a triplet of words, where
a word is represented by a 90-dimensional vector; a triplet is then termed a ‘contextual
pattern vector’ (an equivalent to this would be to a hypothetical 270-parameter panel of
measurements in our context).
The algorithm which clusters these ‘fingerprints’ of documents is explained by the
Van Gassen team. A grid of nodes (equivalent to random points in the dataset) is created,
where each node corresponds to some point in a space (where dimensionality equals the
number of measured parameters). Individual points from the dataset (contextual vectors
or individual cell measurements) are then assigned to the closest neighbouring node. This
node and all its neighbour nodes which find themselves closer than a set value (ε) shift
14
toward the newly processed point by a distance determined by a learning factor (α). As
the algorithm is fed more points and the map is trained, both ε and α decrease.
As Kohonen elaborates, the finished map can be used to separate the given space
into regions by deeming the nodes seeds to which we assign regions (bins) consisting of
events closest to the particular node.
In contrast, the Van Gassen team presents FlowSOM, a tool for cytometry, which
constructs a minimal spanning tree as output of the analysis (shown in figure 5). In this
structure, the nodes are interconnected in such a way that the weights of branches (connec-
tions) are minimised. The team advises users of FlowSOM to select a number of clusters
that is higher than the expected number of gates one would acquire by manual gating.
This way, previously unknown cell populations or transitioning cells can be captured in
the output. Ultimately, a meta-clustering process can be carried out, whereby the most
similar of the many clusters produced are merged.
Figure 5. A minimal spanning tree as output of FlowSOM applied to a bone marrow
dataset (Van Gassen et al., 2015). With a pie chart displayed for every node, the displayed
relative representation of various markers can serve to identify various cell populations.
The authors of FlowSOM applied the algorithm to a human bone marrow (BM)
mass cytometry experiment. Staining for 31 markers, two of the samples used were one
of unstimulated BM cells and one of cells stimulated by IL-3 (a factor in maturation of
progenitors). After a manual gating of single cells, 13 surface markers were used to build
the map. Various cell populations (including naïve and memory T-cells and B-cells, NK
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cells, myeloid populations, different progenitor stages, etc.) were identified. FlowSOM
also allowed the team to look at elevation in some intracellular markers (the pSTAT5
and pSTAT3 signal transducers) that was caused by IL-3 stimulation in the compartment
capturing most plasmacytoid dendritic cells (pDCs; found in peripheral lymphoid organs).
This may serve as some evidence that the clusters created by FlowSOM were sensible, as
the algorithm was not fed data pertaining to these intracellular markers, yet it uncovered
a population which would elicit a response via these markers.
Due to its relatively short runtimes and the ability to detect obscure cell popula-
tions, I find FlowSOM particularly interesting as a method to extract information from
large mass cytometry datasets, related, for instance, to haematopoiesis and its disorders.
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3 B-cell lymphopoiesis
Lymphopoiesis is the differentiation of immunocytes of the lymphoid lineage. These in-
clude B- and T-lymphocytes and natural killer (NK) cells, all important for the ability of
the human immune system to function (explained in Horejsi et al., 2017).
B-cells (B-lymphocytes) are a subset of immunologically relevant cells with roles in
both humoral and cell-mediated immunity. They express surface immunoglobulin (anti-
bodies) with a wide range of specificities which allow them to recognise foreign antigens
in the body. B-cell development takes place in the bone marrow, with mature B-cells
migrating to secondary lymphoid organs (eg. spleen, lymphatic nodes) where they are
stimulated by foreign antigens, diversify their repertoir of antibodies and differentiate into
different subsets, including memory B-cells and plasma cells (this is reviewed by LeBien
and Tedder, 2008).
The result of successful B-lymphopoiesis is establishment of a repertoire of naïve
cells which generally do not respond to stimulation to self-antigens in the body, but are
ready to react to contact with a foreign antigen. For this to happen, progenitors must
be stimulated by adhesive molecules and cytokines, invoking signalling pathways and
transcriptional factors which, in turn, cause the expression of different genes. This includes
the expression of molecular machinery which rearranges immunoglobulin gene segments,
leading to the creation of B-cell receptors that can have different specificities. This occurs
through an interesting process of introducing double-strand breaks to DNA, which is
usually a sign of damage, and joining non-homologous DNA coding ends.
The following chapters describe the differentiation of a haematopoietic stem cell
(HSC) to a common lymphoid progenitor (CLP) and its development into a pro-B cell
(which initiates somatic recombination of immunoglobulin heavy chain genes) and pre-B
cell (which expresses a pre-B cell receptor with a surrogate immunoglobulin light chain).
Moreover, the creation of an immature B-cell with a functional B-cell receptor and its
testing for autoreactivity is addressed. It is shown that cytometry and cell sorting play
a big role in reasearch into these processes. Ultimately, the role of mass cytometry in
uncovering the developmental trajectories of human B-lymphocytes is evaluated.
3.1 Origin of the common lymphoid progenitor
Lymphopoiesis begins with the differentiation of haemotopoietic stem cells (HSCs) in fetal
liver or adult bone marrow into cells which are committed to lymphoid lineage (common
lymphoid progenitors).
For identification of lymphoid progenitor cells which emerge from HSCs, the CD34
surface protein marker is used extensively. First described through the binding of a murine
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antibody and subsequent cell sorting (Katz et al., 1985), CD34 had later been detected to
also mark stromal cell populations of the marrow (Simmons and Torok-Storb, 1991). It was
later found that in murine lymphopoiesis, CD34 mostly marks short-term non-renewing
multipotent progenitors downstream from HSCs; a CD34-/low phenotype (Osawa et al.,
1996) with positivity in CD38 (a glycoprotein with adhesion and signalling functionalities)
would then act as a better indicator for purifying HSCs in FACS analyses (Morrison and
Weissman, 1994). Yet in humans, CD34 expression was succesfully used for gating long-
term renewing HSC populations (Okuno et al., 2002). Another marker of progenitor cells
is the c-Kit (CD117) receptor tyrosine kinase: a proto-oncogene which mediates survival
and proliferation by inactivating pro-apoptotic proteins in the cell (Edling and Hallberg,
2007).
Stromal cells in the bone marrow stimulate HSCs via adhesion and release of cy-
tokines. Adhesion, chiefly via the VCAM-1 (vascular cell adhesion molecule-1) sialoglyco-
protein, has been shown in mice through labelling by antibodies with radioactive iodine
isotopes (Jacobsen et al., 1996) and the disruption of stromal cell-HSC aggregates by
injection of anti-VCAM-1 antibodies (Funk et al., 1994).
Furthermore, adhesion via the transmembrane N-cadherin protein, as well as a
stronger binding via CXCL12 (Burk et al., 2015) was demonstrated for humans on a
mesenchymal stromal cell model. The presence of CXCR4, a corresponding chemokine
receptor, has been verified via flow cytometry of CD34+ progenitor cells (Möhle et al.,
2013), where some CD34+ leukaemic cells were also found unable to undergo migration
across bone marrow endothelia.
Initially, HSCs differentiate into multipotent progenitor cells (MPPs), with continu-
ous CD38 upregulation observed in developmental trajectories inferred from mass cytom-
etry panels. (Bendall et al., 2014; Bagwell et al., 2015). As opposed to HSCs, the MPPs
represent an oligopotent population with reduced capability of self-renewal; the creation
of MPPs is associated with expression of the tyrosine kinase 3 (Flt-3; CD135) cytokine
receptor in mice (Adolfsson et al., 2005). In humans, however, Flt-3 expression already
occurs in the previous developmental stage—the HSC—as confirmed by flow cytometric
analyses (Kikushige et al., 2008), where significant Flt-3 expression was observed both
in earlier CD38-negative and later positive populations (figure 6 shows a partial gating
strategy from this study).
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Figure 6. A contour plot from Kikushige et al. (2008) showing a short gating strategy for
CD34+-sorted bone marrow mononuclear cell. Lineage-specific marker-negative cells are
gated and CD38-negative and positive gates are applied. In addition to selection of signif-
icant human (h) Flt-3 populations, some negative correlation between CD38 and CD90 (a
surrogate HSC marker, used as indicator of pluripotency) is apparent on the level of the
given population, along with a greater portion of hFlt-3- events in the CD38+ compartment.
Subsequent differentiation into common lymphoid progenitor cells (CLPs) is in-
tertwined with effects of interleukin-7 (IL-7), secreted by stromal cells. Stimulation of
the IL-7R receptor is a feature which accompanies creation of CLPs, as opposed to
myeloid progenitors (Johnson et al., 2005), where dose-dependent proliferation of puri-
fied CD19+/IL-7R+ cells occured upon treatment with IL-7, via induced phosphorylation
of STAT5, involved in further signalling. Some researchers recognise lymphoid-primed
multipotent progenitors (LMPPs) as a preceding stage in lymphoid development (Dias
et al., 2008). LMPPs are characterised as cells which may give rise to lymphoid lineages
and some myeloid lineages (granulocytes or macrophages, yet not erythroid cell subsets).
These cells express Flt-3 and this expression may overlap with IL-7R expression, otherwise
common for CLPs (Adolfsson et al., 2005). Expression of the E2A transcription factors is
crucial for lymphoid specification (discussed later; Dias et al., 2009).
The expression of Flt-3 in LMPPs and later stages is at least partly enabled by
the Ikaros transcription factor. Ikaros is a chromatin regulator with a protein-binding
and DNA-binding zinc finger cluster (for dimerisation and activating transcription, re-
spectively) in most of its isoforms (Molnár and Georgopoulos, 1994). Sun et al. (1996)
describe multiple forms, created by alternate splicing of the Ikaros transcript–some re-
inforcing interaction with DNA and some repressing it by inhibiting other Ikaros (Ik)
proteins.
In attempts to specify the point where T-lymphopoiesis and B-lymphopoiesis di-
verge, the Ly6D surface marker was identified as specifying a B-cell fate by a flow cytomet-
ric analysis (Inlay et al., 2009). By mapping this onto the HSC-to-MPP-to-LMPP-to-CLP
timeline, most prospective T-cells were observed to branch out during the LMPP phase
of development. Among all CLPs, the Ly6D marker would enable identification of those
progenitors which would produce B-cells exclusively, as opposed to those which were un-
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restricted as to which lymphoid population they would create.
3.2 Commitment to the B-lineage
The common lymphoid progenitor later commits to development into B-cells. To unravel
the main processes that lead up to this commitment, let us first evaluate the significance
of an important cytokine, interleukin-7, and its signalling at this stage.
The impact of interleukin-7 on human B-cell development is controversial and di-
verse. In a 1996 work by Pribyl et al., a human bone marrow CD34+/CD19- cell culture
(where CD19, a prominent signalling adaptor, marks most B-cell stages) was isolated us-
ing FACS to demonstrate the ability to commit to the B-lineage without IL-7. (Crucially,
this cell culture originated from a fetus.) This is in contrast with the findings of Peschon
et al. (1994) who used flow cytometry to demonstrate deficiency in cells expressing heat
stable antigen (HSA/CD24; B-cell marker) in adult mutant mice.
Fetal B-cell development is distinct in that other cytokines, including thymic stro-
mal lymphopoietin (TSLP), produced by various stromal cells and epithelia, may seem to
fulfill some approximate roles of IL-7 (Voßhenrich et al., 2003). TSLP promotes develop-
ment of immature B-cells by both fetal liver and adult bone marrow cell cultures in mice.
Furthermore, its effect is impeded by monoclonal antibodies against the IL-7Rα chain of
the IL-7 receptor dimer, whereas the same approach to block the other (γc) chain of the
receptor shows no effect (Levin et al., 1999). The same mechanism seems to be responsible
for the apparently normal B-cell counts in patients with X-linked severe common immun-
odeficiencies (XSCIDs) lacking a functional γc chain of IL-7R (Puel et al., 1998), where
TSLP was suggested as a substitute for IL-7 in adult progenitors (as tested on mice by
Chappaz et al., 2007). The role of TSLP as this substitute, however, has been challenged
since. Jensen et al. (2008) conducted several comparative analyses and identified the Flt-3
ligand as a more proximate actor in fetal B-lymphopoiesis. Moreover, findings on the role
of TSLP in human B-cell development are scarce, with a singular in vitro study suggesting
that TSLP contributes to the commitment of fetal progenitors, with the two chains of the
TSLP receptor (IL7-Rα and TSLPR) expressed more in the bone marrow than the liver
(Scheeren et al., 2010).
Luckily, a study by Parrish et al. (2009) managed to clarify the matter as it relates
to IL-7 and FLT-3 in humans. Using human-only co-cultures of neonatal cord blood (CB)
or adult bone marrow (BM) progenitors and human stroma, the work suggests more than
60-fold increases in CD34+ and CD34- B-cell precursor counts in both CB and BM upon
stimulation by IL-7. However, a consistent ‘baseline’ of CD19lo progenitor production
was only observed in CB, while the in vitro generative capabilities of BM cells decreased
along different stages of ontogeny, rendering IL-7 progressively more important in regular
B-lymphopoiesis.
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A number of signalling pathways (JAK-STAT, Src, PI3K/Akt, MAPK/Erk) has
been observed in action as a result of IL-7 signalling, using some mouse and human models
(as reviewed by Corfe et al., 2012). A plethora of transcription factors are implicated in
futher stages of B-cell development.
One of the prominent transcription factors, implicated in assisting the transition to
the CLP and the pro-B cell, is the PU.1 protein. PU.1-deficient mice (with a null mutation)
die in early development; Schweitzer and DeKoter (2004) used flow cytometry to quantify
the related changes in CD19+ cell counts which document B-cell count reductions. While
the mutants were deficient in pro-B cells, those transducted with an IL-7Rα retroviral
vector restored some IL-7 signalling. Interestingly, Inomata et al. (2006) observed a
negative correlation between expression of PU.1 and Flt-3 in mice with acute myeloblastic
leukaemia (AML) where Flt-3 was over-expressed, showing the possible role of PU.1 as a
repressor of an flt3 promoter in the cell. In general, lower levels of PU.1 are observed to
correlate with commitment to the B-lineage, while elevated levels are typical of myeloid
lineage commitment, back at the LMPP stage of development (DeKoter et al., 2002).
The early B-cell factor (EBF) is a protein which promotes commitment to the B-
lineage in particular, in synergy with E2A proteins. EBF acts both as an antagonist to
pro-myeloid factors (including PU.1) and promoter of Pax5, an actor in repressing genes
specific for other lineages (Pongubala et al., 2008), yet EBF can act independently of it.
The E12 and E47 transcription factors, created via alternative splicing from the
E2A gene, also induce Pax5 transcription, and have been implicated in enabling transcrip-
tion of the recombinase needed for later Ig segment rearrangement, the CD19 signalling
adaptor and other important proteins needed for B-cell maturation (Bain et al., 1994), as
inferred from observing deficient mice.
Moreover, in human T-cell lymphoma patients suffering from deletion of E2A, the
c-Myc protoncogene, which usually remains down-regulated, and Cyclin-dependent kinase
6 (Cdk6), which regulates transition to S-phase in the cell cycle and the tumor suppres-
sor retinoblastoma protein (pRB), are expressed at abnormally high levels (Steininger
et al., 2011); this documents the role of E2A as a suppressor of tumor growth. Aber-
rant distributions of the proliferating cells by phases in the cell cycle were observed via
flow cytometry: bromodeoxyuridine (BrdU), analogue of thymine, conjugated with al-
lophycocyanin (APC), was incorporated into the DNA of malignant cells and staining
with 7-Aminoactinomycin D (7-AAD; a DNA intercalator used for determining cell cycle
phases) followed. One of the cell cultures was transfected with E47. Gating of cells by
stages of the cell cycle was possible by distinuishing the various clusters through correlating
DNA content with relative amounts of incorporated BrdU (indicative of DNA synthesis).
An E47-stimulated culture showed a significantly smaller portion of cells in S-phase and
a higher portion in the G0/G1 phases, corroborating the evidence from quantitative PCR
pointing to E2A-DNA binding as a mechanism of repressing cancerogenesis.
21
3.3 The pro-B cell and its fate
The pro-B cell is the stage at which somatic recombination, leading up to the eventual
expression of a pre-B cell receptor (a predecessor to the full B-cell receptor), is initiated.
The transition to pro-B cells can be identified by some increase in expression of
CD19 and CD10 (and endopeptidase often used in diagnostics of cancerogenesis) and CD22
(a transmembrane lectin structurally related to immunoglobulin molecules, tracking devel-
opment along the one-dimensional B-lymphopoietic continuum). A CD34+CD10+CD19+TdT+
phenotype (where TdT is the terminal transferase in the nucleus, see below) is character-
istic for pro-B cells (Bagwell et al., 2015; Bendall et al., 2014).
Earlier, we referred to the Pax5 transcription factor as appearing ‘downstream’
of EBF and E2A. Pax5-deficient pro-B cells retain their potential to differentiate into
myeloid cells and fail to develop into B-cells (Heavey et al., 2003; Urbánek et al., 1994).
Holmes et al. (1992) report that Pax5-deficient cells fail to repress Flt-3 transcription,
whereas after reintroducing Pax5, the pro-B cells retain this ability. This may elucidate
the mechanism by which PU.1 deficiencies cause Flt-3 overexpression. Some pertinent
data from immunodeficient patients are available with regard to Pax5 deficiency (Kaneko
et al., 1998). As observed in this study, CD19-expression was found to correlate with
Pax5, which corroborates the findings of Kozmik et al. (1992) who isolated Pax5 as a
‘B-cell specific activation protein’.
The transition from a lymphoid progenitor to the pro-B cell stage is accompanied by
the initial stages of DNA recombination, leading toward the eventual creation of a pre-B-
cell receptor (pre-BCR). The expression of a recombinase is essential for the rearrangement
of gene segments that precedes the formation of a pre-BCR. The recombinase activity gene-
1 (RAG-1) was identified as a principal actor. The expression of RAG-1 along with RAG-2
is common to both B- and T-lineage progenitors (Schatz et al., 1989). Oettinger et al.
(1990) found that transfects with RAG-2 showed increased frequencies of recombination.
The previously discussed Ikaros transcription factor was identified to induce expres-
sion of the RAG-1–RAG-2 complex [the V(D)J recombinase] in the following experiment.
Reynaud et al. (2009) transfected some MPPs deficient in Ikaros with a retroviral vector
carrying EBF. The EBF-transfected cells achieved, albeit delayed and limited, differentia-
tion into CD19+ precursors, whereas the group transfected with a control retrovirus went
on to produce myeloid cells. (This rescue of B-lineage potential could not be achieved by
E2A or Pax5, however.) Nonetheless, the generated CD19+ cells were unable to express
the Rag1 and Rag2 genes, as well as the Dntt gene, coding terminal deoxyribonucleotidyl-
transferase (TdT; discussed later).
Matthews et al. (2007) report on a particular conserved tryoptophan residue of
RAG-2 which allows for the recognition of a nucleosome where histone 3 is trimethylated
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at position-4 lysine (H3K4me3). The structure responsible for the RAG-2–H3K4me3 bind-
ing is a PHD finger (a cysteine and histidine residue-containing motif often involved in
interactions with histones), as revealed in sequencing by Callebaut and Mornon (1998).
Prior to the rearrangement of gene segments in the Igh (immunoglobulin heavy
chain) loci, these segments migrate from the transcriptionally repressed nuclear periphery
to central regions of the nucleus in the early pro-B cell (Kosak et al., 2002), wherein IL-7
stimulation appears to amplify this process. The IgH gene consists of the VH (‘variable’),
DH (‘diversity ’) and JH (‘joining ’ or ‘junctional ’) regions. A mechanism of looping within
the gene for IgH brings the V region closer to the D/J cluster within the Igh structure, as
observed via fluorescent in-situ hybridisation of the three regions by Sayegh et al. (2005).
Hewitt et al. (2009) observed that homologues within the IgH loci across chromosomes
pair up under the influence of RAG-1–RAG-2.
Subsequently, the V(D)J recombinase facilitates the joining of some DH and JH
segments in the pro-B cell (preceding VH-to-DH joining). Critically, a few hundred V-
segments, about 50 D-segments and 9 J-segments are present, ensuring an element of
randomness in which of the segments are connected (Horejsi et al., 2017). This random-
ness, however, is kept at bay by a principle dubbed the 12/23 spacer rule. As explained by
Steen et al. (1996), the conserved recombination signal sequences (RSSs) contain a hep-
tamer sequence adjacent to the coding segment and a 12- or 23-nucleotide spacer sequence
in the opposite direction, followed by a conserved nonamer sequence. The Steen team es-
tablished that cleavage only occurs between RSSs of different spacer lengths, preventing,
for instance, VH-to-VH joining, by the same spacer lengths.
The recombinase complex binds two RSSs to create double-strand breaks (DSBs) in
the DNA structure during the G1 phase of the cell cycle, bringing the two sites together via
a synapse (Bredemeyer et al., 2008). The complex causes a nick in the 5’ (phosphorylated)
end of the RSS. The other strand of DNA is cleaved in the corresponding spot, leaving
a 3’ hydroxyl group exposed at the other strand. At this point, a gap is formed between
a coding end and the signal end. A phosphodiester bond joins the coding end strands to
create an intermediate hairpin structure (Van Gent et al., 1996). The cleavage process
occurs at each of the two RSSs. Interestingly, the RAG proteins alone, even in a non-
cellular system, were found sufficient for carrying out these steps by McBlane et al. (1995).
The mechanism is curious in that these breaks usually occur in a malignant context.
Non-homologous end joining (NHEJ) triggers repair mechanisms, otherwise neo-
plasm or death of the cell would ensue. The two coding ends, one within the DH cluster
and one within the JH cluster, need to be connected. In NHEJ, a DNA-dependent protein
kinase–catalytic subunit (DNA-PKcs), the Artemis specific nuclease, DNA ligase IV and
other components are recruited.
Firstly, the DSB is detected by the Ku heterodimer (the ∼70kDa and ∼80kDa
Ku70 and Ku80 polypeptides). Ku, identified first as an autoimmune antigen, contains a
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ring structure near the C-terminus which binds to the major groove at the site of the DSB
and a conserved sequence at the extreme C-terminus. This sequence recruits the DNA-
PKcs (Radhakrishnan and Lees-Miller, 2017), a large (4000 amino-acid) serine/threonine
protein kinase from the phosphatidylinositol-3-kinase family which comprises many sig-
nalling proteins involed, for example, in cell survival (Hartley et al., 1995). The DNA-PKcs
dimerises by creating a synapse with another DNA-PKcs at the other coding end. Only
after this synapse is formed, auto- and transphosphorylation occurs between the two units
of the polypeptide (Hammel et al., 2010). Publications refer to the Ku heterodimer and
the catalytic subunit collectively as DNA-PK.
Subsequently, the Artemis endonuclease is recruited via its C-terminal region by
the DNA-PKcs dimer. Artemis is a useful piece of cellular machinery: reported to be ‘the
only vertebrate nuclease capable of opening DNA hairpins’ (Chang and Lieber, 2016),
the N-terminal nuclease in Artemis has been observed to tackle a number of structures,
including Y-shaped DNA structures, loops, bubbles and others, achieving to open them
when in association with DNA-PKcs (Ma et al., 2005). Ijspeert et al. (2011) describe
reductions both in B- and T-cell counts in two patients with different null mutations
in the gene for Artemis. In addition to supressed V(D)J recombination, the absence of
Artemis increased susceptibility to ionising radiation, which was employed to introduce
double-strand breaks in DNA.
A motif in the C-terminal region of Artemis binds the DNA-binding domain of DNA
ligase IV (LigIV; an enzyme with the ability to connect DNA strands via a phosphodiester
bond), which occurs in complex with the DNA repair protein XRCC4. (Calsou et al.
/2003/ confirm, via immunoprecipitation studies, the sequentiality of the steps in NHEJ,
showing that recruitment of the XRCC4-LigIV complex is dependent upon the assembly of
the Ku-DNA-PKcs complex.) XRCC4 functions as a scaffolding protein, with the ability
to form multimeric structures with other units of XRCC4 or other proteins involved in
the NHEJ process (reviewed by Williams et al., 2014). XRCC4 forms a super-helical
structure which organises into filaments, where the XRCC4-like factor (XLF) binds into
hydrophobic pockets of XRCC4 via a key leucine residue (Hammel et al., 2011). LigIV
contains a tandem of two breast cancer susceptibility gene C-terminal (BRCT) domains,
also occurent in other proteins involved in DNA repairs, which binds to XRCC4, as found
by Critchlow et al. (1997) via common immunoprecipitation of the two. At this stage,
LigIV is able to rejoin the two coding ends and create a recombined DJH segment. Figure
7 gives an overview of NHEJ.
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Figure 7. A schematic representation of double-strand breaks and non-homologous end
joining in the context of V(D)J recombination (self, 2018).
The NHEJ model is a versatile approach to repairing double-strand breaks in the
cell. An additional feature exclusive to lymphocytes, however, comes into play to increase
the repertoire of possible outcomes which arise from the recombination. The terminal de-
oxynucleotidyl transferase (TdT) is a curious type of DNA polymerase, with the ability to
elongate a 3’ overhang, with no need for a second strand as a template (Chang, 1971). TdT
was found to attach ‘extra’ nucleotides in a stochastic manner to both coding and signal
ends of DNA (Lieber et al., 1988). The enzyme shows a consistent preference for dGTP
and dCTP, which can be regulated by a variety of metal cations (Chang and Bollum,
2009). Let us focus again on the coding ends trimmed by Artemis-DNA-PKcs as inter-
mediates in the NHEJ process. When the hairpin structure at a coding end is trimmed,
the hairpin does not open symmetrically at the tip (where it was sealed) but rather at
one strand closer to the D- or J-segment. Therefore, upon opening, the hairpin structure
unravels and reveals a sequence which is, by principle, palindromic, termed P-nucleotides
(reviewed by Motea and Berdis, 2010). If this occurs in the context of V(D)J recombina-
tion, TdTs attach deoxynucleoside triphosphates to either Artemis-trimmed coding end,
extending a non-templated (N) region at the 3’ overhang at either side. Mickelsen et al.
(1999) state the average number of added deoxynucleotide triphosphates lies in the range
from 2 to 5. After the creation of N regions, the two regions on either of the coding ends
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align homologically over a short segment which happens to fit with respect to the classi-
cal base-pairing rules. Overhangs which interfere with the homology are removed by the
Artemis–DNA-PKcs complex or other exonucleases involved (Motea and Berdis, 2010).
Adjacent to the V, D and J gene segments are C (constant) segments, responsible
for the immunoglobulin isotype. Different isotypes have distinct roles in antigen-specific
response. The repertoire of immunoglobulin isotypes expands tremendously during class-
switch recombination later on (Horejsi et al., 2017).
3.4 From pro-B cell to pre-B cell
The transition to a pre-B cell, which expresses a pre-B cell receptor (IgH with a light
chain surrogate), is marked, among other processes, by increasing IgH expression and
an eventual rise in surface CD19 expression. Pre-B cells may then be gated based on a
CD34-CD19+CD10+CD38+TdT- phenotype (Bagwell et al., 2015; Bendall et al., 2014).
After successful somatic D-J regrouping, the process is repeated to bring the VH
segment to DJH in a late pro-B cell (Alt et al., 1984). With a VDJH segment ready for
transcription, the pro-B cell can proceed by expressing an immunoglobulin heavy chain
(IgH), which is an integral part of a B-cell receptor. Kitamura and Rajewsky (1992)
investigated the mechanism of allelic exclusion, whereby a successful IgH rearrangement
process at one chromosome halts V-DJ recombination at the other chromosome. In ad-
dition to a lack of signalling via a functional pre-BCR, they identified mRNA coding for
a viable membrane form of the heavy chain of isotype M as a trigger for the exclusion.
Lutz et al. (2011), using flow cytometry for quantifications of cells from mutant mice,
observed realiable response upon accumulation of μH mRNA that was not targeted by
nonsense-mediated mRNA decay (NMD), which eliminates mRNA with premature termi-
nation codons. As demonstrated in the paper, stable yet noncoding mRNA can be created
to avoid NMD, yet still suppress V-DJ recombination at the other chromosome, effectively
halting development of the cell.
Allelic exclusion ensures a single clonotype of antibodies produced per B-cell. Bar-
reto and Cumano (2000) found, using FACS with multiple anti-IgM and other stains, that
only about 1 in 10 000 murine splenic B-cells showed dual IgH expression. This was pre-
sumably due to the inability of the first mRNA to form a functional pre-BCR receptor
or due to synchronous expression at both chromosomes. The fascinating mechanism of
exclusion based on mRNA seems to explain the relative effectiveness of the process.
Similar to a mature B-cell receptor, the pre-BCR needs two heavy chain units, two
light chain units and other co-receptor proteins to assemble. The μHC (heavy chain) is
joined by a surrogate ψLC (light chain) and an Igα/Igβ (CD79a/CD79b) transmembrane
heterodimer. The surrogate light chain is a non-covalently bound complex of the VpreB
and λ5 proteins, with λ5 binding to a μH C-subunit via a cystein residue (reviewed by
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LeBien, 2000). Takeshi and Reth (1990) showed transfecting deficient cells to express
these two proteins will enable IgH expression, where the IgH would otherwise be retained
in the endoplasmic reticulum.
Upon assembly, the complete pre-BCR causes signalling via multiple protein-tyrosine
kinases (more in Benschop, 1999). A B-cell specific linker molecule is of considerable in-
terest as a modulator of signalling. BLNK (or SPL-65), a target of the Pax5 transcription
factor, is responsible for pre-BCR signalling and has been identified as the proximal factor
in developmental arrest due to Pax5 deficiencies (Schebesta et al., 2002).
3.5 Toward the immature B-cell
Transition toward an immature B-cell is accompanied by a CD19+, CD20+ phenotype
and down-regulation of the CD10 and CD38 markers. Immature B-cells express surgace
IgM which include physiologic light chains (Bagwell et al., 2015). Recombination of Ig
light chain gene segments, contingent upon pre-BCR signalling, occurs in a similar fashion
to IgH recombination. However, D-segments are absent (a V-J recombination occurs)
and the mechanism of terminating recombination differs. Two types of Ig light chains
are encoded: Igκ and Igλ. First, the V- and H-segments at the IGK locus undergo
rearrangements until such mRNA is transcribed that is able to associate with the μH
chain, creating a complete surface immunoglobulin. However, Igκ production fails at
both chromosomes, Igλ production commences. This was first postulated upon observing
leukaemic cells as a model by Alt el al. (1980) and corroborated by Asenbauer et al.
(1999) who noted that the transcriptional enhancer for Igλ has limited accessibility to a
DNase, as opposed to the Igκ enhancer. Hence, in addition to allelic exclusion, an isotypic
exclusion (κ versus γ) takes place, resulting in a majority of BCRs only containing a single
light-chain isotype. However, Giachino et al. (1995) used FACS to confirm an existent
κ+/λ+ phenotype and indicated that allelic inclusion may also result in dual expression of
the same isotype. Xu (2006) reports on dual light-chain expression in some B-cell chronic
lymphocytic leukaemias, observed via flow cytometry.
With a complete B-cell receptor complex, comprised of surface IgM (sIgM) and
Igα/Igβ, the immature B-cell is tested for autoreactivity prior to leaving the marrow.
3.6 Testing for autoreactivity
Multiple mechanisms are involved in establishing central B-cell tolerance. Immature IgM+
B-lymphocytes are subjected to processes which weed out self-reactive cells. Wardemann
et al. (2003) list some features of the complementarity-determining region 3 (CDR3;
determinant of antibody specificity) in surface Ig which serve as indication of self-reactivity.
These include increased length of CDR3 as well as increased share of positively-charged
27
amino acids. The portion of cells with such a phenotype decreased with progression
toward mature B-cells; furthermore, the team used ELISA to test reactivity with various
cell lysates and human cell antigens. Their conclusion was to estimate that between 55
and 75% of immature B-cells express self-reactive surface Ig.
3.6.1 Receptor editing
Gay et al. (1993) published a seminal paper on receptor editing: examining the fate of
autoreactive immature B-cells in transgenic mice, the team found the cells to show de-
layed expression of newly rearranged IgL chains. Cytometry confirmed that the newly
edited BCRs would not bind self-antibodies, when the original mutant BCRs did. Further
results pointed toward the cells’ ability to re-express activator genes for the reassembly
of the V(D)J recombination machinery upon the multivalent cross-linking of sIgM when
encountering a self-antigen (Tiegs et al., 1993). The possibility of multiple IgL rearrange-
ments at this stage is documented (Yamagami et al., 1999). In addition, most of the
primary rearrangements result in the use of the 1st and 2nd Jκ regions, with multiple J
and V regions left intact for potential secondary rearrangements. Autoreactive mutants
were observed to retain the same number of B-cells as wild-type subjects (Pelanda et al.,
1997).
As the Tiegs team reminds us, immature B-cells have the potential to express as
many as 2 H chains and 6 L chains simultaneously, only barred by allelic and isotypic
exclusion, lending some credence to an editing model, as opposed to mere deletion of
self-reactive cells. This line of reasoning proves sensible: Chen et al. (1995) identified
an analogous secondary rearrangement mechanism in IgH in transgenic autoreactive cells.
However, these rearrangements are rather more complex than in the case of IgL: two re-
arrangements (D-to-J and V-to-DJ) were originally needed for a functional IgH segment
recombination (detailed above). Fanning et al. (1998) describe a heptamer sequence adja-
cent to the 3’ end of most VH segments, which is used often in the secondary rearrangement
as a new RSS, enabling replacement of the VH segment by a different one. Moreover, a
less-frequent direct VH-to-JH joining, leading to omission of the DH segment, was observed
(Koralov et al., 2006). However interesting this mechanism of secondary rearrangement of
IgH is, Zhang et al. (2003) found that only about 5 % of functional human IgH sequences
bore a footprint of this process.
Crucially, Schram et al. (2008) postulate a ‘threshold’ for antigen stimulation (via
tonic signalling) needed to halt Rag expression and receptor editing. The group worked
with transgenic mice HEL-specific Ig and GFP-tagged RAG2 (allowing for quantification
via flow cytometry). They showed that immunodeficient subjects with decreased classical
BCR signalling (which occurs via cross-linking and recruitment of the Btk kinase) showed
no decrease in receptor editing, refuting a link between acute BCR cross-linking and
editing in the given conditions. Furthermore, when stimulated by the self-antigen in vitro,
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both control and immunodeficient cells showed minute RAG2–GFP expression. Surface
activation markers CD69 and CD86 were monitored, as Ag was introduced in ‘pulses’:
RAG2 expression showed a notable delay when compared to these markers; in addition,
its eventual up-regulation was similar in the control and immunodeficient cell populations.
In contrast to this, cells deficient in the lyn Src family kinase (responsible for Igα and Igβ
phosphorylation) saw elevated levels of RAG2-GFP, suggesting a distinct mechanism in
accordance with a basal signalling model.
3.6.2 Clonal deletion
Once thought to be the prevalent mechanism for establishing central B-cell tolerance,
clonal deletion of autoreactive cells was inferred from studies using early transgenic mouse
models. For instance, Nemazee and Buerki (1989) observed the apparent loss of transgenic
self-specific B-cells, originally targeting MHC class I (a histo-compatibility molecule), both
in the marrow and spleen. The team attributed this effect to prevalent clonal deletion of
those B-cells in the marrow which reacted to the autologous antigen.
A subsequent study by Hartley et al. (1993) described an initial stage of devel-
opmental arrest followed by hypothesised apoptosis. However, shift in forward and side
scatter (in cytometry) or chromatin condensation, indicative of apoptosis, was, conspicu-
ously, not detected in the immature B-cell population. Due to the inability of this team
to capture cell death, they stated at the time it ‘[could not] be excluded that the B cells
may persist but lose all cell surface markers’ or that other cells encompass the apoptotic
vesicles. While it is apparent that some clonal deletion takes place, it appears to mostly
occur in cases of failure to generate a non-autoreactive secondary rearrangement of the
BCR (described above and reviewed by Pelanda and Torres, 2012).
3.6.3 Anergy
The result of immature B-cell receptor testing is not a dichotomy. Some antigen bind-
ing with avidity brings about a state of anergy. A key study by Goodnow et al. (1988)
described transgenic immature B-cells targeted at hen-egg lysozyme (HEL), which was
also expressed. In defiance of a supposed clonal deletion mechanism for eliminating self-
reactive cells, a number of them appeared in secondary lymphoid organs, with increased
internalisation of IgM. Benschop et al. (2001) studied a transgenic immature B-cell pop-
ulation binding a bone marrow autoantigen; whereas no receptor editing was observed,
activation markers (including the B220 activation marker) were seen in flow cytometry.
However, the nascent mature B-cells showed no signalling upon BCR stimulation. Later,
Merrell et al. (2006) identified anergic B-cells in the periphery in wild-type mouse and
Quach et al. (2011) complemented these findings, investigating a population of human
naïve B-cells with abnormally low IgM expression and impaired signalling.
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3.7 Revealing a developmental trajectory
To get a comprehensive picture of B-cell development, let us evaluate some studies which
take advantage of single-cell technology to reveal the trajectory which the aforementioned
progenitors follow.
An example of an early study of transitioning populations is a work by Terstappen
et al. (1991). The group conducted a five-dimensional analysis of bone marrow cells. In
an attempt to order transitioning populations of B-lymphoid cells, they identified a steady
increase in CD38 and slowed decrease in CD34, with a significant CD10 expression increase
characteristic for B-lymphopoiesis. These transitioning populations could be visualised
using combinations of two-dimensional dot-plots, thanks to the relatively small number of
parameters measured.
As to more recent studiues, mass cytometry is of great use. In a 2014 project, Ben-
dall et al. developed a 44-parameter marker panel and an algorithm for both clustering
populations within ∼200,000-cell sets and ordering the measured events along a contin-
uum (shown in figure 8), dubbed Wanderlust. A graph-based method, Wanderlust finds
neighbours of cells along a developmental trajectory not by simply identifying the closest
different data point, but by constructing a sensible path from point A to point B which
covers all the intermediate points on its way. Wanderlust creates multitudes of possible
trajectories and constructs a consensus path, which mostly avoids this ‘short-circuiting’
(false connections). The trajectory must be non-branching, rendering B-cell lymphopoiesis
a good candidate for testing the algorithm.
Figure 8. Intensity of signal from some CD markers was normalised and used to char-
acterise B-cell development. Adapted from Bendall et al. (2014).
Interestingly, the non-parametric∗ Spearman correlation coefficient (ρ) never dropped
under ± 0.97 (with maximum at 1) with the exclusion of any one parameter from the anal-
∗Because the statistical test is non-parametric, the rank (i.e. ordering) of datapoints along a pseudo-
time continuum is important, rather than an exact measure of their position on this scale.
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ysis. The choice of a correct starting point for the analysis, however, is important, due to
the zero branching assumption. The paths generated by Wanderlust were consistent with
quantitative PCR (qPCR) analysis focused on changes in IgH as a metric of development.
The results were also consistent across different individuals.
After constructing the developmental trajectory, the group investigated the signif-
icance of IL-7 signalling, marked by activation of STAT5 kinase (used as an intracellular
marker) in humans. Wanderlust found a single phenotypically distinct population of cells
(about 0.007% of total) which saw an approximately five-fold increase in STAT5 acti-
vation, showing a narrow timeframe where IL-7 signalling functions as a checkpoint for
IgH rearangement. Importantly, STAT5 activation was not a known parameter to Wan-
derlust, showing an extraordinary ability to reveal checkpoints in cell development from
juxtaposing abundant data from many markers that are examined simultaneously.
Bagwell et al. (2015) investigated the sequentiality of some stages in B-lymphopoiesis.
They point to the problematic nature of synthesising knowledge from cord blood and bone
marrow samples, quantifying cell populations based on manual gates or studying malignan-
cies to draw conclusions regarding healthy lymphopoiesis. The team used the GemStone
software for probability state modelling (PSM): a complex algorithm which calculates the
most probable ordering of events.
The team first ran an ‘unconstrained’ analysis, which identified 6 ‘control definition
points’, which seem critical in the progression. This way, a sharp down-regulation of
CD34, subsequent slight increase in CD45, a second CD45 up-regulation coinciding with
sharp CD20 up-regulation and the virtually simultaneous drop in CD38 and CD10 were
identified; developmental stages were then mapped onto a progression axis (see figure 9).
Interestingly, the B3 stage (corresponding to an immature B-cell stage) was either subtle
or not observed in some samples upon individual inspection.
Figure 9. An average model of lymphopoiesis after B-lineage commitment, using relative
intensities of various markers. Statistically inferred developmental stages (B1 to B4) are
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shown (Bagwell et al., 2015).
The group also presents the ability of GemStone to constrain the analysis, allowing
the user to force some crucial changes in marker expression to coincide on the progression
axis. This provides an exciting framework to build robust models of lymphopoiesis and
use them to compare aberrant data from patients and identify the aetiology of their illness.
4 Conclusion
B-cell lymphopoiesis is a convoluted and critical process in the immune system. Using
various markers and stains, high-throughput single-cell technology can help identify dis-
tinct populations of cells and serve as a powerful tool in explaining the processes within
B-cell development.
From supression of various oncogenes, proper adhesion signalling, transcription of
genes for commitment to a particular myeloid or lymphoid lineage to somatic rearrange-
ment processes for assembling a functional antigen receptor, haematopoiesis is made up
of nuanced trajectories. Many molecular mechanisms within these trajectories are not
understood in their entirety.
With the advent of mass cytometry coupled with novel smart approaches to automa-
tised clustering of populations, new opportunities to aggregate data regarding haematopoiesis
are emerging. If our knowledge regarding healthy blood development is robust, objective
models can be built to serve as templates for diagnosis of malignancies and a better under-
standing of disease aetiology can be established. New opportunities for targeted therapy
can be explored. Also, differences between mouse models and human patients can be
investigated in depth.
Cluster analyses and algorithms which reveal complicated developmental trajecto-
ries, combined with good understanding of genetics, might bring about an era in which
artificial intelligence provides sound judgement in diagnostics and treatment of leukaemias
and immunodeficits, steered by medical professionals, biologists and informaticians who
oversee the process.
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